Skip to main content
. 2018 Apr 26;23(9):1008–1015. doi: 10.1634/theoncologist.2017-0629

Figure 1.

image

The genetic profiles in different age groups of patients with lung adenocarcinoma. One hundred seventy‐seven patients with lung adenocarcinoma patients were enrolled, and tissue samples were analyzed by NGS assays. The frequency of targeted genetic alterations across three age groupings was compared to determine an age cutoff point that could differentiate young patients with a distinctive molecular profile. Statistical significance was defined as p < .05.